Acylcarnitine Profiles in Plasma and Tissues of Hyperglycemic NZO Mice Correlate with Metabolite Changes of Human Diabetes

The New Zealand obese (NZO) mouse is a polygenic model for obesity and diabetes with obese females and obese, diabetes-prone males, used to study traits of the metabolic syndrome like type 2 diabetes mellitus (T2DM), obesity, and dyslipidaemia. By using LC-MS/MS, we here examine the suitability of t...

Full description

Saved in:
Bibliographic Details
Main Authors: Anna Weiser, Pieter Giesbertz, Hannelore Daniel, Britta Spanier
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2018/1864865
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564265325690880
author Anna Weiser
Pieter Giesbertz
Hannelore Daniel
Britta Spanier
author_facet Anna Weiser
Pieter Giesbertz
Hannelore Daniel
Britta Spanier
author_sort Anna Weiser
collection DOAJ
description The New Zealand obese (NZO) mouse is a polygenic model for obesity and diabetes with obese females and obese, diabetes-prone males, used to study traits of the metabolic syndrome like type 2 diabetes mellitus (T2DM), obesity, and dyslipidaemia. By using LC-MS/MS, we here examine the suitability of this model to mirror tissue-specific changes in acylcarnitine (AC) and amino acid (AA) species preceding T2DM which may reflect patterns investigated in human metabolism. We observed high concentrations of fatty acid-derived ACs in 11 female mice, high abundance of branched-chain amino acid- (BCAA-) derived ACs in 6 male mice, and slight increases in BCAA-derived ACs in the remaining 6 males. Principal component analysis (PCA) including all ACs and AAs confirmed our hypothesis especially in plasma samples by clustering females, males with high BCAA-derived ACs, and males with slight increases in BCAA-derived ACs. Concentrations of insulin, blood glucose, NEFAs, and triacylglycerols (TAGs) further supported the hypothesis of high BCAA-derived ACs being able to mirror the onset of diabetic traits in male individuals. In conclusion, alterations in AC and AA profiles overlap with observations from human studies indicating the suitability of NZO mice to study metabolic changes preceding human T2DM.
format Article
id doaj-art-6d2b6aa963114595a4db36d7acb780c1
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-6d2b6aa963114595a4db36d7acb780c12025-02-03T01:11:22ZengWileyJournal of Diabetes Research2314-67452314-67532018-01-01201810.1155/2018/18648651864865Acylcarnitine Profiles in Plasma and Tissues of Hyperglycemic NZO Mice Correlate with Metabolite Changes of Human DiabetesAnna Weiser0Pieter Giesbertz1Hannelore Daniel2Britta Spanier3Nutrition Physiology, Technische Universität München, Gregor-Mendel-Str. 2, 85350 Freising, GermanyNutrition Physiology, Technische Universität München, Gregor-Mendel-Str. 2, 85350 Freising, GermanyNutrition Physiology, Technische Universität München, Gregor-Mendel-Str. 2, 85350 Freising, GermanyNutrition Physiology, Technische Universität München, Gregor-Mendel-Str. 2, 85350 Freising, GermanyThe New Zealand obese (NZO) mouse is a polygenic model for obesity and diabetes with obese females and obese, diabetes-prone males, used to study traits of the metabolic syndrome like type 2 diabetes mellitus (T2DM), obesity, and dyslipidaemia. By using LC-MS/MS, we here examine the suitability of this model to mirror tissue-specific changes in acylcarnitine (AC) and amino acid (AA) species preceding T2DM which may reflect patterns investigated in human metabolism. We observed high concentrations of fatty acid-derived ACs in 11 female mice, high abundance of branched-chain amino acid- (BCAA-) derived ACs in 6 male mice, and slight increases in BCAA-derived ACs in the remaining 6 males. Principal component analysis (PCA) including all ACs and AAs confirmed our hypothesis especially in plasma samples by clustering females, males with high BCAA-derived ACs, and males with slight increases in BCAA-derived ACs. Concentrations of insulin, blood glucose, NEFAs, and triacylglycerols (TAGs) further supported the hypothesis of high BCAA-derived ACs being able to mirror the onset of diabetic traits in male individuals. In conclusion, alterations in AC and AA profiles overlap with observations from human studies indicating the suitability of NZO mice to study metabolic changes preceding human T2DM.http://dx.doi.org/10.1155/2018/1864865
spellingShingle Anna Weiser
Pieter Giesbertz
Hannelore Daniel
Britta Spanier
Acylcarnitine Profiles in Plasma and Tissues of Hyperglycemic NZO Mice Correlate with Metabolite Changes of Human Diabetes
Journal of Diabetes Research
title Acylcarnitine Profiles in Plasma and Tissues of Hyperglycemic NZO Mice Correlate with Metabolite Changes of Human Diabetes
title_full Acylcarnitine Profiles in Plasma and Tissues of Hyperglycemic NZO Mice Correlate with Metabolite Changes of Human Diabetes
title_fullStr Acylcarnitine Profiles in Plasma and Tissues of Hyperglycemic NZO Mice Correlate with Metabolite Changes of Human Diabetes
title_full_unstemmed Acylcarnitine Profiles in Plasma and Tissues of Hyperglycemic NZO Mice Correlate with Metabolite Changes of Human Diabetes
title_short Acylcarnitine Profiles in Plasma and Tissues of Hyperglycemic NZO Mice Correlate with Metabolite Changes of Human Diabetes
title_sort acylcarnitine profiles in plasma and tissues of hyperglycemic nzo mice correlate with metabolite changes of human diabetes
url http://dx.doi.org/10.1155/2018/1864865
work_keys_str_mv AT annaweiser acylcarnitineprofilesinplasmaandtissuesofhyperglycemicnzomicecorrelatewithmetabolitechangesofhumandiabetes
AT pietergiesbertz acylcarnitineprofilesinplasmaandtissuesofhyperglycemicnzomicecorrelatewithmetabolitechangesofhumandiabetes
AT hanneloredaniel acylcarnitineprofilesinplasmaandtissuesofhyperglycemicnzomicecorrelatewithmetabolitechangesofhumandiabetes
AT brittaspanier acylcarnitineprofilesinplasmaandtissuesofhyperglycemicnzomicecorrelatewithmetabolitechangesofhumandiabetes